Preliminary real-world trends in outpatient revenue following implementation of disease-modifying therapies in general hospital psychiatry in Japan.

Abstract

Implementation of anti-amyloid disease-modifying therapy (DMT) within a psychiatry-led dementia care program enabled structural transformation of service delivery in a general hospital setting. A multidisciplinary model integrating psychiatry, neurology, and radiology facilitated coordinated care and safe treatment implementation. This approach was associated with increased outpatient revenue per patient without a corresponding increase in workforce burden, suggesting that high-value neuropsychiatric treatments can shift psychiatry from a cost center to a revenue-generating service.